4.3 Article

Chorioretinal Atrophy in Punctate Inner Choroidopathy/multifocal Choroiditis: A Five-year Follow-up Study

Journal

OCULAR IMMUNOLOGY AND INFLAMMATION
Volume 30, Issue 2, Pages 270-275

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/09273948.2020.1869269

Keywords

Chorioretinal atrophy; punctate inner choroidopathy; multifocal choroiditis; long-term outcome; white dots syndrome

Categories

Ask authors/readers for more resources

This retrospective study reported the 5-year progression of chorioretinal atrophy (CRA) in patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC). The results showed a significant increase in CRA size with a progression rate associated with axial length and initial PIC lesion number. Aggressive treatment is suggested for eyes with higher initial lesion numbers and longer axial length to control faster CRA progression.
Purpose: To report the 5-year results of chorioretinal atrophy (CRA) progression in patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC). Methods: A retrospective study included PIC/MFC patients with secondary CRA formation. The area of CRA was measured and the progression rate was calculated. Multiple regression analysis was performed to investigate risk factors associated with CRA progression. Results: Forty-five eyes of 36 patients were included. The mean CRA size significantly increased after an average of 4.83 years of follow-up with progression rate of 0.69 mm(2)/year. Moreover, we had identified the axial length and initial PIC lesion number as significant risk factors for CRA progression. Conclusion: Significant CRA enlargement is noted in PIC/MFC patients after 5 years of follow-up. The progression rate is associated with axial length and initial PIC numbers. Aggressive treatment is suggested for eyes with more initial lesion numbers and longer axial length to control the faster CRA progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available